Hofland J, Kaltsas G, de Herder WW. Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms. Endocr Rev. 2020;41:371–403.

Article  PubMed  PubMed Central  Google Scholar 

Masui T, Ito T, Komoto I, et al. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Int J Clin Oncol. 2022;27:840–9.

Article  PubMed  PubMed Central  Google Scholar 

de Herder WW, Rehfeld JF, Kidd M, Modlin IM. A short history of neuroendocrine tumours and their peptide hormones. Best Pract Res Clin Endocrinol Metab. 2016;30:3–17.

Article  PubMed  Google Scholar 

Muneer M. Hypoglycaemia. Adv Exp Med Biol. 2021;1307:43–69.

Article  CAS  PubMed  Google Scholar 

Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67–74.

CAS  PubMed  Google Scholar 

Ding Y, Wang S, Liu J, Yang Y, Liu Z, et al. Neuropsychiatric profiles of patients with insulinomas. Eur Neurol. 2010;63:48–51.

Article  PubMed  Google Scholar 

Murakami T, Yamashita T, Yabe D, et al. Insulinoma with a history of epilepsy: still a possible misleading factor in the early diagnosis of insulinoma. Intern Med. 2017;56:3199–204.

Article  PubMed  PubMed Central  Google Scholar 

Munir A, Choudhary P, Harrison B, Heller S, Newell-Price J. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol. 2018;68:912–8.

Article  Google Scholar 

Sugawa T, et al. Hypoglycemia unawareness in insulinoma revealed with flash glucose monitoring systems. Intern Med. 2018;57:3407–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tesfaye N, Seaquist ER. Neuroendocrine response to hypoglycemia. Ann N Y Acad Sci. 2010;1212:12–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dizon AM, Kowalyk S, Hoogwerf BJ. Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med. 1999;106:307–10.

Article  CAS  PubMed  Google Scholar 

Imamura M, Nakamoto Y, Uose S, Komoto I, Awane M, et al. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015;22:602–9.

Article  PubMed  Google Scholar 

Dai H, Chen H, Hong X, Han X, Xu Q, et al. Early detection of cognitive impairment in patients with insulinoma. Endocrine. 2019;65:524–30.

Article  CAS  PubMed  Google Scholar 

Moser O, Eckstein ML, McCarthy O, Deere R, Pitt J, et al. Performance of the freestyle libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: a secondary outcome analysis of a randomized crossover trial. Diabetes Obes Metab. 2019;21:2505–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, et al. Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences. Pharmaceuticals (Basel). 2021;14:238.

Article  CAS  PubMed  Google Scholar 

Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin. Nature. 1995;374:542–6.

Article  CAS  PubMed  Google Scholar 

Orthen-Gambill N, Salomon M. Differential effects of psychotropic drugs on feeding in rats: is histamine blockade involved? Pharmacol Biochem Behav. 1990;36:837–41.

Article  CAS  PubMed  Google Scholar 

Weston-Green K, Huang XF, Lian J, et al. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels. Eur Neuropsychopharmacol. 2012;22:364–73.

Article  CAS  PubMed  Google Scholar 

Yamamoto N, Oh E, Nishiyama K, Yoshida M, Saeki A, et al. Case of insulinoma manifesting as hyperinsulinemia after discontinuing quetiapine in an elderly patient with delirium. Geriatr Gerontol Int. 2017;17:849–51.

Article  PubMed  Google Scholar 

Suzuki M, Niidome K, Maeda K, Kikuchi T, Usami T, et al. Preclinical pharmacological profiles and clinical efficacy of the novel antipsychotic drug brexpiprazole (REXULTI Tablets 1mg, 2mg). Nihon Yakurigaku Zasshi. 2019;154:275–87.

Article  CAS  PubMed  Google Scholar